1. Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer

   • Handoo Rhee
   • Ian Vela
   • Eric Chung

   Review 06 November 2015 Pages: 75 - 83

   

2. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer

   • Christopher Foley
   • Nicholas Mitsiades

   Review 04 January 2016 Pages: 84 - 103

   

3. Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression

   • Ailin Zhang
   • Jiawei Zhang
   • Elahe A. Mostaghel

   Review 21 January 2016 Pages: 104 - 113

   

4. Hsp90 Inhibition Results in Glucocorticoid Receptor Degradation in Association with Increased Sensitivity to Paclitaxel in Triple-Negative Breast Cancer

   • Abena S. Agyeman
   • Wesley J. Jun
   • Suzanne D. Conzen

   Original Paper 08 February 2016 Pages: 114 - 126

   

5. Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk

   • Robert T. Chatterton
   • Richard E. Heinz
   • Seema A. Khan

   Original Paper 22 February 2016 Pages: 127 - 136

6. Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model

   • Nathalie Esber
   • Clément Cherbonnier
   • Nathalie Chabbert-Buffet

   Original Paper 03 March 2016 Pages: 137 - 147